Stocks are up Friday, with the Dow Jones Industrial Average up 1.06%, the Nasdaq up 0.74% and the S&P 500 up 0.82%. Friday’s winners include a company beating second-quarter earnings and a biotech firm soon to announce results for a clincal trial. The loser had its price target cut by a prominent analyst.
These are Friday’s market winners and loser.
Biggest Winners
Shares of Splunk, Inc. (NASDAQ: SPLK) are up 17.93% to $35.97 on trading volume of 1.9 million shares. While the data-mining software company reported a second-quarter loss of 1 cent a share, it was better than Wall Street expectations of a 4-cent-a-share loss. The 52-week high is $37.57.
Shares of StemCells Inc. (NASDAQ: STEM) are up 12.24% to $2.20 on trading volume of 5 million shares. The biotechnology company’s stock is rallying before it announces results of a clinical durg trial to treat chronic spinal cord injury. The 52-week high is $2.55.
Biggest Loser
Shares of Facebook Inc. (NASDAQ: FB) are down 3.92% to $18.34 on trading volume of 25.5 million shares. BMO Capital has cut its price target to $15. Before Friday, the 52-week low was $18.75.
Samuel Weigley
Follow him on Twitter: SWeigley
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
